Joseph Grieco

Park Therapeutics, Inc.

NIH Rank #2190
  • Early Career

NIH Funding · FY2024

Total Funding
$3.3M
Fiscal year 2024
Grants Awarded
1
Active NIH grants
National Rank
#2,190
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $3.3M across 1 grant · National rank #2190.

Top grants by award amount

Joseph Grieco's NIH grant portfolio, ranked by award amount.

  • 5UG3DA059285-02UG3
    Development of cebranopadol, a potent dual MOP/NOP agonist, for the treatment of Opioid Use Disorder (OUD)
    $3.3M
    award amount

Affiliation

Institutions that have administered grants for Joseph Grieco.

Affiliated with Park Therapeutics, Inc. (NJ).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Park Therapeutics, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #2190
  6. 2024
    Entered Top 25% Nationally
    Ranked #2190

Related investigators

Other NIH-funded PIs frequently associated with Joseph Grieco.